The trademark application BICYCLE was filed by Bicycletx Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 18, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Pharmaceutical preparations
Pharmaceutical products
Pharmaceutical products and preparations for use in relation to oncology
Pharmaceutical products and preparations for use in relation to ophthalmology
Pharmaceutical products and preparations for use in relation to neurology
Anti-infective pharmaceutical products and preparations
Pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease
Pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease
Pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease
Pharmaceutical products and preparations for the treatment and/or prevention of viral infections
Pharmaceutical products and preparations for use in diagnostics and imaging
Pharmaceutical products and preparations for the treatment and/or prevention of renal disease
Pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease
Pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and design relating thereto
Industrial analysis and research services
Pharmaceutical research and development services
Medical research and development services
Pharmaceutical testing and clinical trials
Clinical trials
Research and development in the field of oncology
Research and development in the field of ophthalmology
Research and development in the field of neurology
Research and development in the field of anti-infective pharmaceuticals
Research and development in the field of respiratory disease
Research and development in the field of cardiovascular disease
Research and development in the field of metabolic disease
Research and development in the field of antiviral drugs
Research and development in the field of diagnostics and imaging
Research and development in the field of renal disease
Research and development in the field of gastrointestinal disease
Research and development in the field of muscular skeletal disease
Information consultancy and advisory services relating to the aforesaid.
The mark was filed in class 44 with following description of goods:
Medical services
Healthcare services
Pharmaceutical services
Medical consulting services
Advisory services relating to pharmaceuticals
Consultancy and information services relating to pharmaceuticals
Medical services in the field of oncology
Medical services in the field of ophthalmology
Medical services in the field of neurology
Medical services in the field of anti-infectives
Medical services in connection with respiratory disease
Medical services in connection with cardiovascular disease
Medical services in connection with metabolic disease
Medical services in connection with the treatment and/or prevention of viral infections
Medical services in connection with diagnostics and imaging
Medical services in connection with renal disease
Medical services in connection with gastrointestinal disease
Medical services in connection with muscular skeletal disease
Pharmaceutical services in the field of oncology
Pharmaceutical services in the field of ophthalmology
Pharmaceutical services in the field of neurology
Pharmaceutical services in the field of anti-infectives
Pharmaceutical services in connection with respiratory disease
Pharmaceutical services in connection with cardiovascular disease
Pharmaceutical services in connection with metabolic disease
Pharmaceutical services in connection with the treatment and/or prevention of viral infections
Pharmaceutical services in connection with diagnostics and imaging
Pharmaceutical services in connection with renal disease
Pharmaceutical services in connection with gastrointestinal disease
Pharmaceutical services in connection with muscular skeletal disease
Information, consultancy and advisory services relating to the aforesaid.